Mild Cognitive Impairment - Epidemiology - Emerging Markets Data
Total Prevalence of Mild Cognitive Impairment per 1,000 Among People Aged 65 or Older in 2016 and 2026
Relative Sizes of the Contributing Factors to the Trend in Total Prevalent Cases of Mild Cognitive Impairment over the Next Ten Years
Total Prevalent Cases of Mild Cognitive Impairment by Subtype
Subtype - Amnestic/non-amnestic
Studies Included in the Analysis of Mild Cognitive Impairment
Studies Excluded from the Analysis of Mild Cognitive Impairment
Risk/Protective Factors for Mild Cognitive Impairment
Nishant Kumar, M.P.H.
Nishant Kumar, M.P.H., is a senior director on the Epidemiology team at Clarivate. His areas of expertise are oncology and CNS diseases, including Alzheimer’s disease and dementia. His key interests in oncology are modeling disease progression and drug-treatable incident and prevalent populations. Previously, Mr. Kumar sized patient populations for rare and niche diseases, such as graft-versus-host disease and Duchenne muscular dystrophy. He earned his M.P.H. with a concentration in epidemiology and statistics from King’s College in London and a B.Sc. (Honors) in medical studies from the University of Birmingham.